跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,100 条关于
“compound #15”
全部
10,100
临床试验
2,282
药物
1,037
机构
145
资讯
6,636
8个月前
Korea University Researchers Revive NK1 Receptor as Depression Target Through Novel Molecular Design
2个月前
FDA Advisory Panel Begins Review to Loosen Restrictions on Unapproved Peptides Amid Safety Concerns
8个月前
Solvonis Therapeutics' SVN-15 Matches Prozac Efficacy in Depression Model, Targets Dual Serotonin-Dopamine Pathway
去年
FDA Issues Warning Letters to Seven Companies Marketing Illegal Opioid Alternative Products Containing 7-Hydroxymitragynine
去年
Simulations Plus Invests $1 Million in Clinical Trial Technology Company Nurocor
去年
Aldevron Establishes Innovation Center in Boston Biotech Hub to Accelerate Genomic Medicine Development
去年
CSPC Pharmaceutical Secures NMPA Approval for Dupixent in COPD, Marking First Biologic Treatment for China's 65 Million Patients
去年
Alembic Pharma Shares Surge Following USFDA Clearance of Panelav Oncology Facility
上个月
Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb for Second Lead Compound in Cardiovascular RNA Collaboration
去年
October 2024 Clinical Compound Updates: Trial Results and Regulatory Decisions
第 1 页,共 664 页
上一页
下一页